Christopher Peetz - Feb 3, 2025 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Feb 3, 2025
Transactions value $
-$438,921
Form type
4
Date filed
2/4/2025, 05:30 PM
Previous filing
Jan 27, 2025
Next filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale -$439K -9.1K -7.28% $48.22 116K Feb 3, 2025 Direct F1
holding MIRM Common Stock 209K Feb 3, 2025 By The Peetz Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.